These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38894565)

  • 21. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
    Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
    Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
    Baldo A; Lodi G; Di Caterino P; Monfrecola G
    G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety Comparison of Basic Fibroblast Growth Factor-Related Decapeptide 0.1% Solution (bFGFrP) Plus Oral PUVA Combination Therapy with Oral PUVA Monotherapy in the Treatment of Vitiligo.
    Nayak CS; Kura MM; Banerjee G; Patil SP; Deshpande A; Sekar S; Sharma A; Pathak R; Sarma P
    J Cutan Aesthet Surg; 2023; 16(1):28-33. PubMed ID: 37383981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrocautery Needling and the 308-nm Excimer Lamp: A Synergistic Combination for the Treatment of Stable Non-segmental Vitiligo.
    Yang L; Wong PM; Yang L; Katayama I; Wu H; Zhang H
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):695-705. PubMed ID: 32441031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy of Tacrolimus 0.1% ointment and Tacrolimus 0.1% plus topical pseudocatalase/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial.
    Alshiyab DM; Al-Qarqaz FA; Muhaidat JM; Alkhader YS; Al-Sheyab RF; Jafaar SI
    J Dermatolog Treat; 2022 Feb; 33(1):146-149. PubMed ID: 32048900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study.
    Kanokrungsee S; Pruettivorawongse D; Rajatanavin N
    J Cosmet Dermatol; 2021 Mar; 20(3):812-818. PubMed ID: 32744369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary study on the treatment of vitiligo with carbon dioxide fractional laser together with tacrolimus.
    Chen W; Zhou Y; Huang FR; Luo D; Wang DG
    Lasers Surg Med; 2018 Oct; 50(8):829-836. PubMed ID: 29635693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study.
    Seneschal J; Duplaine A; Maillard H; Passeron T; Andreu N; Lassalle R; Favary C; Droitcourt C; Taïeb A; Ezzedine K
    J Invest Dermatol; 2021 Jul; 141(7):1728-1734. PubMed ID: 33549606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical Tacrolimus Ointment Alone versus in Combination with Microneedling for Refractory Stable Vitiligo.
    Kiran A; Khan S; Ahmed N; Ali M
    J Coll Physicians Surg Pak; 2024 May; 34(5):514-517. PubMed ID: 38720208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
    Tanghetti EA
    Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo.
    Kumar D; Thakur V; Subburaj K; Bishnoi A; Vinay K; Sendhil Kumaran M; Parsad D
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2243-2248. PubMed ID: 37467136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
    Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
    Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
    Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
    J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study on the use of fractional CO
    Bakr RM; Abdel-Gaber RM; Tawfik YM
    Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: A randomized double-blind comparative study.
    Juntongjin P; Sangganjanavanich P
    Dermatol Ther; 2021 Mar; 34(2):e14886. PubMed ID: 33595885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.